SlideShare a Scribd company logo
Three Initiatives and Two Support Packages
ADNeT in a Nutshell
• Clinical Quality Registry (CQR) for newly diagnosed
dementia or “mild cognitive impairment”
• Memory Clinics – expand, standardize and support
• Clinical Trial sites – expand and support
• Longitudinal (n=4,000) and Trial ready (n=500) cohorts –
blood, MRI, cognition, amyloid and tau PET, +/- CSF every 2 years
ADNeT Tech
1.Provide IT infrastructure and support for the key ADNeT initiatives
2.Develop and harmonise innovative diagnostic technologies (i.e. PET
and MRI imaging and blood and CSF biomarkers).
The Australian Imaging Biomarkers and Lifestyle
Study of Ageing
.
Commenced late 2006
0m 18m 36m 54m 72m 90m 108m 126m
CN 1476 1034 776 684 523 419 376 219
MCI 394 174 107 79 59 34 28 19
AD 427 286 219 127 68 44 30 6
Other 17 7 10 12 8 6 3 2
Total 2314 1501 1112 902 658 503 437 246
Cumulative
Withdrawn 468 681 838 986 1066 1129 1153
% Follow up
complete 81% 68% 61% 49% 40% 37% 21%
AIBL cohort : Number of assessments
3,500 researchers granted access to AIBL data via
www.adni.loni.usc.edu
Includes access granted to 112 companies e.g.:
Abbott Labs, Abiant, ADM diagnostics, Astra Zeneca, Avid, BioClinica, Biogen Idec, Bristol-Myers Squibb, Cogstate Cytokinetics, Eisai, Elan, Eli Lilly, GE Health Care,
General Resonance, Genetech, Imorphics, Iris Biotechnologies, Janssen, Johnson Johnson, M and M Scientific, Merck & Co, Mimvista, Pentara Corp, Pfizer, Philips,
Predixion software, Rancho Biosciences, Servier, Siemens, Soft team solutions, UCB, United Biosource Corp.
AIBL has also received 250 Expressions of Interest for access to more detailed data.
Bangladesh
China
Hong Kong
India
Indonesia
Japan
Kyrgyzstan
Malaysia
Pakistan
Philippines
Singapore
South Korea
Taiwan
Thailand
Australia
New Zealand
Iran
Iraq
Israel
Saudi Arabia
Turkey
Canada
Cuba
Martinique
Mexico
Puerto Rico
USA
Argentina
Bolivia
Brazil
Chile
Colombia
Ecuador
Guyana
Netherlands Antilles
Peru
Uruguay
Austria
Belgium
Bulgaria
Cyprus
Denmark
Estonia
Finland
France
Algeria
Egypt
Ghana
Morocco
Nigeria
Tunisia
Germany
Greece
Hungary
Ireland
Italy
Lithuania
Luxembourg
Macedonia
Netherlands
Norway
Poland
Portugal
Romania
Russia
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
UK

More Related Content

Similar to Australian Dementia Network (ADNet)

GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
NVIDIA Taiwan
 
John Gallacher - What next
John Gallacher - What nextJohn Gallacher - What next
John Gallacher - What next
angewatkins
 
Lecture-2-amber.pdf
Lecture-2-amber.pdfLecture-2-amber.pdf
Lecture-2-amber.pdf
MohammadIslam814740
 
Hcc 2012
Hcc 2012Hcc 2012
Hcc 2012
mafeeshfayda
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
Kanhu Charan
 
UK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - TagliaviniUK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - Tagliavini
UKinItaly
 
What is a Brain CT Imaging Perfusion Study?
What is a Brain CT Imaging Perfusion Study?What is a Brain CT Imaging Perfusion Study?
What is a Brain CT Imaging Perfusion Study?
Carestream
 
Challenges and improvements in diagnostic services across seven day services
Challenges and improvements in diagnostic services across seven day services Challenges and improvements in diagnostic services across seven day services
Challenges and improvements in diagnostic services across seven day services
NHS Improving Quality
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Oleg Kshivets
 
Deep Learning for AI (3)
Deep Learning for AI (3)Deep Learning for AI (3)
Deep Learning for AI (3)
Dongheon Lee
 
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
Ernesto Diaz
 
The Osprey Programme - Training Clinical Systems Engineers
The Osprey Programme - Training Clinical Systems Engineers The Osprey Programme - Training Clinical Systems Engineers
The Osprey Programme - Training Clinical Systems Engineers
Lean Enterprise Academy
 
10 rencontres biomédicale LIR Faiez Zannad
10 rencontres biomédicale LIR Faiez Zannad10 rencontres biomédicale LIR Faiez Zannad
10 rencontres biomédicale LIR Faiez Zannad
Association LIR
 
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic ApproachNeurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
MS Trust
 
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
Joris van Dijk
 
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
Scintica Instrumentation
 
ASESORIA Y MANEJO PARA LA HIPERTENSION A
ASESORIA Y MANEJO PARA LA HIPERTENSION AASESORIA Y MANEJO PARA LA HIPERTENSION A
ASESORIA Y MANEJO PARA LA HIPERTENSION A
PlanificacinFamiliar
 
CV Chris van Groeningen English Feb 2016
CV Chris van Groeningen English Feb 2016CV Chris van Groeningen English Feb 2016
CV Chris van Groeningen English Feb 2016Chris Van Groeningen
 

Similar to Australian Dementia Network (ADNet) (20)

GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
GTC Taiwan 2017 CUDA 加速先進影像分析技術與深度學習於臨床電腦斷層掃瞄肝細胞腫瘤輔助診斷
 
John Gallacher - What next
John Gallacher - What nextJohn Gallacher - What next
John Gallacher - What next
 
Lecture-2-amber.pdf
Lecture-2-amber.pdfLecture-2-amber.pdf
Lecture-2-amber.pdf
 
Hcc 2012
Hcc 2012Hcc 2012
Hcc 2012
 
ROSE CASE CARDIAC ARRHYTHMIA SBRT
ROSE CASE CARDIAC  ARRHYTHMIA SBRTROSE CASE CARDIAC  ARRHYTHMIA SBRT
ROSE CASE CARDIAC ARRHYTHMIA SBRT
 
UK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - TagliaviniUK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - Tagliavini
 
What is a Brain CT Imaging Perfusion Study?
What is a Brain CT Imaging Perfusion Study?What is a Brain CT Imaging Perfusion Study?
What is a Brain CT Imaging Perfusion Study?
 
Challenges and improvements in diagnostic services across seven day services
Challenges and improvements in diagnostic services across seven day services Challenges and improvements in diagnostic services across seven day services
Challenges and improvements in diagnostic services across seven day services
 
TFG_kevinvallelozano
TFG_kevinvallelozanoTFG_kevinvallelozano
TFG_kevinvallelozano
 
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
Esophageal Cancer: Artificial Intelligence, Synergetics, Complex System Analy...
 
Deep Learning for AI (3)
Deep Learning for AI (3)Deep Learning for AI (3)
Deep Learning for AI (3)
 
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
Centros evaluacion de Riesgo Cardio Vascular en Mexico (rev 170912)
 
The Osprey Programme - Training Clinical Systems Engineers
The Osprey Programme - Training Clinical Systems Engineers The Osprey Programme - Training Clinical Systems Engineers
The Osprey Programme - Training Clinical Systems Engineers
 
10 rencontres biomédicale LIR Faiez Zannad
10 rencontres biomédicale LIR Faiez Zannad10 rencontres biomédicale LIR Faiez Zannad
10 rencontres biomédicale LIR Faiez Zannad
 
IRC_Capabilities
IRC_CapabilitiesIRC_Capabilities
IRC_Capabilities
 
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic ApproachNeurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
Neurological Disorders of the Bladder & Pelvic Floor - A Holistic Approach
 
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
ICNC 2019 (poster) More normal scans but comparable post-test referral after ...
 
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
(June 28th, 2021) Webinar: Applications Overview Using Low Field MRI To Study...
 
ASESORIA Y MANEJO PARA LA HIPERTENSION A
ASESORIA Y MANEJO PARA LA HIPERTENSION AASESORIA Y MANEJO PARA LA HIPERTENSION A
ASESORIA Y MANEJO PARA LA HIPERTENSION A
 
CV Chris van Groeningen English Feb 2016
CV Chris van Groeningen English Feb 2016CV Chris van Groeningen English Feb 2016
CV Chris van Groeningen English Feb 2016
 

More from ARDC

Introduction to ADA
Introduction to ADAIntroduction to ADA
Introduction to ADA
ARDC
 
Architecture and Standards
Architecture and StandardsArchitecture and Standards
Architecture and Standards
ARDC
 
Data Sharing and Release Legislation
Data Sharing and Release Legislation   Data Sharing and Release Legislation
Data Sharing and Release Legislation
ARDC
 
Investigator-initiated clinical trials: a community perspective
Investigator-initiated clinical trials: a community perspectiveInvestigator-initiated clinical trials: a community perspective
Investigator-initiated clinical trials: a community perspective
ARDC
 
NCRIS and the health domain
NCRIS and the health domainNCRIS and the health domain
NCRIS and the health domain
ARDC
 
International perspective for sharing publicly funded medical research data
International perspective for sharing publicly funded medical research dataInternational perspective for sharing publicly funded medical research data
International perspective for sharing publicly funded medical research data
ARDC
 
Clinical trials data sharing
Clinical trials data sharingClinical trials data sharing
Clinical trials data sharing
ARDC
 
Clinical trials and cohort studies
Clinical trials and cohort studiesClinical trials and cohort studies
Clinical trials and cohort studies
ARDC
 
Introduction to vision and scope
Introduction to vision and scopeIntroduction to vision and scope
Introduction to vision and scope
ARDC
 
FAIR for the future: embracing all things data
FAIR for the future: embracing all things dataFAIR for the future: embracing all things data
FAIR for the future: embracing all things data
ARDC
 
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian DuncanARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
ARDC
 
Skilling-up-in-research-data-management-20181128
Skilling-up-in-research-data-management-20181128Skilling-up-in-research-data-management-20181128
Skilling-up-in-research-data-management-20181128
ARDC
 
Research data management and sharing of medical data
Research data management and sharing of medical dataResearch data management and sharing of medical data
Research data management and sharing of medical data
ARDC
 
Findable, Accessible, Interoperable and Reusable (FAIR) data
Findable, Accessible, Interoperable and Reusable (FAIR) dataFindable, Accessible, Interoperable and Reusable (FAIR) data
Findable, Accessible, Interoperable and Reusable (FAIR) data
ARDC
 
Applying FAIR principles to linked datasets: Opportunities and Challenges
Applying FAIR principles to linked datasets: Opportunities and ChallengesApplying FAIR principles to linked datasets: Opportunities and Challenges
Applying FAIR principles to linked datasets: Opportunities and Challenges
ARDC
 
How to make your data count webinar, 26 Nov 2018
How to make your data count webinar, 26 Nov 2018How to make your data count webinar, 26 Nov 2018
How to make your data count webinar, 26 Nov 2018
ARDC
 
Ready, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
Ready, Set, Go! Join the Top 10 FAIR Data Things Global SprintReady, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
Ready, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
ARDC
 
How FAIR is your data? Copyright, licensing and reuse of data
How FAIR is your data? Copyright, licensing and reuse of dataHow FAIR is your data? Copyright, licensing and reuse of data
How FAIR is your data? Copyright, licensing and reuse of data
ARDC
 
Peter neish DMPs BoF eResearch 2018
Peter neish DMPs BoF eResearch 2018Peter neish DMPs BoF eResearch 2018
Peter neish DMPs BoF eResearch 2018
ARDC
 
Connected DMPs at UoA - we have a dream
Connected DMPs at UoA - we have a dreamConnected DMPs at UoA - we have a dream
Connected DMPs at UoA - we have a dream
ARDC
 

More from ARDC (20)

Introduction to ADA
Introduction to ADAIntroduction to ADA
Introduction to ADA
 
Architecture and Standards
Architecture and StandardsArchitecture and Standards
Architecture and Standards
 
Data Sharing and Release Legislation
Data Sharing and Release Legislation   Data Sharing and Release Legislation
Data Sharing and Release Legislation
 
Investigator-initiated clinical trials: a community perspective
Investigator-initiated clinical trials: a community perspectiveInvestigator-initiated clinical trials: a community perspective
Investigator-initiated clinical trials: a community perspective
 
NCRIS and the health domain
NCRIS and the health domainNCRIS and the health domain
NCRIS and the health domain
 
International perspective for sharing publicly funded medical research data
International perspective for sharing publicly funded medical research dataInternational perspective for sharing publicly funded medical research data
International perspective for sharing publicly funded medical research data
 
Clinical trials data sharing
Clinical trials data sharingClinical trials data sharing
Clinical trials data sharing
 
Clinical trials and cohort studies
Clinical trials and cohort studiesClinical trials and cohort studies
Clinical trials and cohort studies
 
Introduction to vision and scope
Introduction to vision and scopeIntroduction to vision and scope
Introduction to vision and scope
 
FAIR for the future: embracing all things data
FAIR for the future: embracing all things dataFAIR for the future: embracing all things data
FAIR for the future: embracing all things data
 
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian DuncanARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
ARDC 2018 state engagements - Nov-Dec 2018 - Slides - Ian Duncan
 
Skilling-up-in-research-data-management-20181128
Skilling-up-in-research-data-management-20181128Skilling-up-in-research-data-management-20181128
Skilling-up-in-research-data-management-20181128
 
Research data management and sharing of medical data
Research data management and sharing of medical dataResearch data management and sharing of medical data
Research data management and sharing of medical data
 
Findable, Accessible, Interoperable and Reusable (FAIR) data
Findable, Accessible, Interoperable and Reusable (FAIR) dataFindable, Accessible, Interoperable and Reusable (FAIR) data
Findable, Accessible, Interoperable and Reusable (FAIR) data
 
Applying FAIR principles to linked datasets: Opportunities and Challenges
Applying FAIR principles to linked datasets: Opportunities and ChallengesApplying FAIR principles to linked datasets: Opportunities and Challenges
Applying FAIR principles to linked datasets: Opportunities and Challenges
 
How to make your data count webinar, 26 Nov 2018
How to make your data count webinar, 26 Nov 2018How to make your data count webinar, 26 Nov 2018
How to make your data count webinar, 26 Nov 2018
 
Ready, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
Ready, Set, Go! Join the Top 10 FAIR Data Things Global SprintReady, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
Ready, Set, Go! Join the Top 10 FAIR Data Things Global Sprint
 
How FAIR is your data? Copyright, licensing and reuse of data
How FAIR is your data? Copyright, licensing and reuse of dataHow FAIR is your data? Copyright, licensing and reuse of data
How FAIR is your data? Copyright, licensing and reuse of data
 
Peter neish DMPs BoF eResearch 2018
Peter neish DMPs BoF eResearch 2018Peter neish DMPs BoF eResearch 2018
Peter neish DMPs BoF eResearch 2018
 
Connected DMPs at UoA - we have a dream
Connected DMPs at UoA - we have a dreamConnected DMPs at UoA - we have a dream
Connected DMPs at UoA - we have a dream
 

Recently uploaded

Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 

Recently uploaded (20)

Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 

Australian Dementia Network (ADNet)

  • 1.
  • 2. Three Initiatives and Two Support Packages
  • 3. ADNeT in a Nutshell • Clinical Quality Registry (CQR) for newly diagnosed dementia or “mild cognitive impairment” • Memory Clinics – expand, standardize and support • Clinical Trial sites – expand and support • Longitudinal (n=4,000) and Trial ready (n=500) cohorts – blood, MRI, cognition, amyloid and tau PET, +/- CSF every 2 years
  • 4. ADNeT Tech 1.Provide IT infrastructure and support for the key ADNeT initiatives 2.Develop and harmonise innovative diagnostic technologies (i.e. PET and MRI imaging and blood and CSF biomarkers).
  • 5. The Australian Imaging Biomarkers and Lifestyle Study of Ageing . Commenced late 2006
  • 6. 0m 18m 36m 54m 72m 90m 108m 126m CN 1476 1034 776 684 523 419 376 219 MCI 394 174 107 79 59 34 28 19 AD 427 286 219 127 68 44 30 6 Other 17 7 10 12 8 6 3 2 Total 2314 1501 1112 902 658 503 437 246 Cumulative Withdrawn 468 681 838 986 1066 1129 1153 % Follow up complete 81% 68% 61% 49% 40% 37% 21% AIBL cohort : Number of assessments
  • 7. 3,500 researchers granted access to AIBL data via www.adni.loni.usc.edu Includes access granted to 112 companies e.g.: Abbott Labs, Abiant, ADM diagnostics, Astra Zeneca, Avid, BioClinica, Biogen Idec, Bristol-Myers Squibb, Cogstate Cytokinetics, Eisai, Elan, Eli Lilly, GE Health Care, General Resonance, Genetech, Imorphics, Iris Biotechnologies, Janssen, Johnson Johnson, M and M Scientific, Merck & Co, Mimvista, Pentara Corp, Pfizer, Philips, Predixion software, Rancho Biosciences, Servier, Siemens, Soft team solutions, UCB, United Biosource Corp. AIBL has also received 250 Expressions of Interest for access to more detailed data. Bangladesh China Hong Kong India Indonesia Japan Kyrgyzstan Malaysia Pakistan Philippines Singapore South Korea Taiwan Thailand Australia New Zealand Iran Iraq Israel Saudi Arabia Turkey Canada Cuba Martinique Mexico Puerto Rico USA Argentina Bolivia Brazil Chile Colombia Ecuador Guyana Netherlands Antilles Peru Uruguay Austria Belgium Bulgaria Cyprus Denmark Estonia Finland France Algeria Egypt Ghana Morocco Nigeria Tunisia Germany Greece Hungary Ireland Italy Lithuania Luxembourg Macedonia Netherlands Norway Poland Portugal Romania Russia Serbia Slovakia Slovenia Spain Sweden Switzerland Ukraine UK